ServiceNow reported Q4 earnings that topped estimates but shares fell on lower-than-expected subscription revenue growth in ...
PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of LaNeotm MDMA and novel derivatives of MDMA (MDXX class ...
Google ( GOOG, GOOGL) and ServiceNow ( NOW) on Wednesday announced plans to bring ServiceNow’s Now Platform to Google’s Cloud ...
ServiceNow , the AI platform for business transformation, announced today an expansion of its strategic alliance with Visa, a world leader in digital payments. Visa plans to use the ServiceNow Dispute ...
Peter Weed, an analyst from Bernstein, maintained the Buy rating on ServiceNow (NOW – Research Report). The associated price target is ...
ServiceNow on Wednesday also reported 21% revenue growth in its fourth quarter and higher profit. Chief Executive Bill McDermott said the company is in the early innings of an opportunity spurred by ...
the Customer Experience Specialization from ServiceNow. Crossfuze is one of only six partners globally to receive any kind of Specialization designation, highlighting the company's position as a ...
We are raising our fair value estimate for ServiceNow NOW to $990 per share from $900 after the company reported fourth-quarter results that were generally in line with or better than our expectations ...
ServiceNow has effectively monetized generative AI, evidenced by strong growth in Gen-AI SKUs and high-value customer deals.
Bank of America Securities analyst Bradley Sills maintained a Buy rating on ServiceNow (NOW – Research Report) today and set a price target of ...